Loading...
In a study of electronic health records from multiple institutions in the U.K., researchers estimated the incidence of neurological or psychiatric sequelae in 236,000 people with COVID-19. During 6 months of follow-up, 13% of patients with no history of neurological or psychiatric conditions received a first diagnosis of such a condition, and another 21% of patients with past neurological or psychiatric conditions developed new conditions.
These rates were compared with rates in 342,000 people (matched for pertinent variables) with influenza or other respiratory tract infections. Incidence of neurological or psychiatric diagnoses were significantly higher in COVID-19 patients: The most common diagnoses were anxiety disorder (17.4%), psychoti…